Siemens Healthineers at ISMRM & SMRT Virtual Conference & Exhibition 2020
Visit Siemens Healthineers at our virtual booth
Book an appointment with our product experts or application specialists here
Exploring new frontiers in Precision Medicine
Join us at this year´s virtual ISMRM and discover how our solutions constantly exceed the possible. The innovative spirit of this unique, vibrant MRI community really comes to life at ISMRM and Siemens Healthineers is proud to be part of this network. The passion for jointly pioneering MRI around the globe is truly unmatched.
To experience the latest MRI developments and gain insights into future innovations, please join our Siemens Healthineers MRI Symposium at the ISMRM 2020.
Time: Monday, August 10th, 2020, 11:00 - 12:00 UTC
Location: The Siemens Healthineers MRI Symposium will be available on the platform of ISMRM & SMRT Virtual Conference & Exhibition.
Exploring new frontiers in MRI
Rise of the machines (in MR image acquisition and reconstruction)
Langone NYU, New York, USA
Deep Learning Image Reconstruction – State of the Art
Imperial College London, UK
Opportunities in clinical imaging using a high-performance 0.55T MRI system
National Institutes of Health, USA
MR Fingerprinting1 – A giant leap for precision medicine
What if we could unlock the power of quantitative data in MR to improve diagnostic accuracy? Magnetic Resonance Fingerprinting (MRF)1 uses quantified information to generate a more precise under¬standing of a patient’s condition. MRF has enormous potential to improve tissue differentiation and enable less invasive diagnostics. Reliable MRF data could increase objective comparisons in follow-up studies. Ultimately, aided by AI, quantitative measurements could lead to more personalized treatment. MRF is at the frontier of a new dimension in quantitative imaging.
BioMatrix Technology – Embrace human nature
BioMatrix Technology embraces human nature in MRI.
Patients have unique, individual characteristics – biovariabilities. Different physiologies and anatomies – but also the way we interact with them and technology – cause unwarranted variations in imaging results. BioMatrix Technology helps to overcome these challenges by embracing human nature: Instead of expecting patients to adjust to the technology, BioMatrix automatically adjusts to the individual patient. Only by embracing human nature can we truly personalize examinations and help expand precision medicine.
MAGNETOM Terra – Translate 7T research power into clinical care
Explore new territories in MRI by enabling powerful 7T research and enhancing clinical care and better patient outcomes. MAGNETOM Terra is the first 7T scanner released for clinical use in Europe and US. The unique Dual Mode lets you switch between clinical and research operations, with separate database to distinguish between clinical and research scans. The advanced ultra-high-field (UHF) technology has the power, to put you firmly at the forefront of MRI – giving you a competitive edge and increasing your reputation as a true opinion leader.
The AI-Rad Companion, our family of AI-powered, cloud-based augmented workflow solutions, helps you to reduce the burden of basic repetitive tasks and may increase your diagnostic precision when interpreting medical images.
Its solutions provide automatic post-processing of imaging datasets through our AI-powered algorithms. For example, the AI-Rad Companion assists in the interpretation of MR images of the brain. The FDA cleared and CE-marked AI-Rad Companion Brain MR for morphometry analysis automatically segments different brain areas and quantifies each of their volumes. These results are compared to a normative database and can easily be assessed by the radiologist through a color-coded deviation map and a quantitative overview. The AI-Rad Companion portfolio includes further offerings that use MRI images for AI-based image quantification. AI-Rad Companion Prostate MR for biopsy support automatically segments the prostate and allows the manual annotations of lesions, which can support in targeted biopsies under MRI and Ultrasound fusion imaging. Targeted, MRI-supported biopsies like this can make it easier for the urologist to detect significant prostate carcinomas and improve the quality of patient care.
1Magnetic Resonance Fingerprinting is currently under development and not commercially available. It is not for sale in the US or other countries. Its future availability cannot be guaranteed.
2Data on file. Results may vary.